Baird Financial Group
ANAC

Baird Financial Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Baird Financial Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-46,184
Closed -$2.47M – 1308
2016
Q1 		$2.47M Buy
46,184
+7,597
+20% +$561K 0.02% 491
2015
Q4 		$4.36M Sell
38,587
-1,171
-3% -$129K 0.04% 373
2015
Q3 		$4.68M Sell
39,758
-16,680
-30% -$2.18M 0.05% 339
2015
Q2 		$4.37M Buy
+56,438
New +$3.7M 0.04% 377

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Baird Financial Group's ANAC Position: Q2 2016 in Review

Baird Financial Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 46,184 shares — an estimated $2.47M sold.

Baird Financial Group first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $4.68M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Baird Financial Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Baird Financial Group sold 46,184 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.47M.
  • Baird Financial Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
  • Baird Financial Group's ANACOR PHARMACEUTICALS INC COM position peaked at $4.68M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Baird Financial Group's 13F filing for Q2 2016, filed 11 Aug 2016.